How light therapy helps heal the brain

Photobiomodulation (PBM) Light Therapy for brain health shows promising results to help heal neurological conditions including Traumatic Brain Injury (TBI), stroke, Parkinson’s, Alzheimer’s and Autism Spectrum Disorders. But why does shining light on the brain offer such a safe and effective therapy, and how does it work?

This article summarises foundational evidence in light therapy for brain health which supports a homeostatic and hormetic model of PBM and addresses ideas to the contrary that PBM may stimulate well-metabolised tissue. We discuss photobiomodulation; low-level laser therapy; mitochondria; cytochrome c oxidase; biphasic dose response; hormesis; metabolic dysfunction; neuro-inflammation.

Why light therapy for the brain is safe

Photobiomodulation Therapy is a safe and effective modality which exerts regulatory effects on cellular metabolism primarily through mitochondrial chromophores, particularly cytochrome c oxidase. Evidence from mechanistic studies, dose-response analyses, and clinical trials indicates that PBM preferentially restores function in metabolically compromised tissue, rather than amplifying already optimal metabolic activity. In basic terms this means that PBM works on dysfunctional tissues or neurones, rather than existing healthy ones. Instead of  ‘stimulating’ healthy tissue (like a vibrational TENS devices for example), PBM modulates tissue health, prioritising unhealthy tissue and increasing the energetic value to that of healthy cells. That’s why it’s called photobiomodulation, not photo-stimulation.

Light Therapy and the Biphasic Dose

Photobiomodulation (PBM) is widely described as enhancing mitochondrial metabolism. However, current literature supports a context-dependent model whereby PBM has stronger effects on hypoxic, inflamed, or metabolically impaired tissue. The Arndt–Schulz principle describes a biphasic dose response wherein low-to-moderate doses stimulate biological activity, whereas excessive doses may inhibit it. This hormetic response is particularly evident in stressed biological systems. PBM light therapy for brain health interacts with cytochrome c oxidase (CCO), restoring electron transport chain efficiency where nitric oxide-mediated inhibition or hypoxia has impaired respiration. ATP restoration and redox normalisation are most pronounced in compromised tissue.

Neurological implications of light therapy for brain health

In neurological tissue, hyper-excitability often coexists with mitochondrial inefficiency and neuro-inflammation. Transcranial PBM studies demonstrate improved cerebral blood flow, reduced inflammatory cytokines, and improved network coherence in traumatic brain injury, depression, and neurodegenerative models. These findings support metabolic rescue rather than indiscriminate stimulation.

A growing body of clinical and translational research supports the conclusion that photobiomodulation (PBM), particularly trans-cranial PBM therapy, has measurable benefits in neurologically compromised brain tissue. These conditions include traumatic brain injury (TBI), mild cognitive impairment (MCI), Alzheimer’s disease, depression, and neuroinflammatory conditions such as Autism Spectrum Disorders (ASD). Importantly, these benefits are consistently demonstrated in pathological contexts, rather than in optimally functioning healthy neural tissue.

Light Therapy for Traumatic Brain Injury (TBI)

Systematic reviews of PBM in chronic TBI report improvements in cognitive function, executive processing, and functional connectivity. Mechanistically, PBM enhances cerebral blood flow, reduces neuroinflammation, and restores mitochondrial respiration in injured tissue. These effects align with a metabolic rescue model of healing, rather than indiscriminate neural stimulation.

Light Therapy for Mild Cognitive Impairment and Alzheimer’s Disease

Clinical investigations in MCI and Alzheimer’s disease suggest improvements in global cognition, memory performance, and quality-of-life metrics following repeated PBM sessions. Proposed mechanisms include enhanced ATP production, reduction of amyloid-associated oxidative stress, and improved cerebral perfusion. These findings support preferential action in metabolically impaired neural networks.

Light Therapy for Depression and Mood Disorders

Randomized and open-label trials in major depressive disorder demonstrate reductions in symptom severity following Photobiomodulation Therapy treatments. Observed physiological changes include improved prefrontal oxygenation and modulation of inflammatory markers. Given that depression is associated with mitochondrial inefficiency and neuro-inflammation, these findings further support the thesis of context-dependent metabolic normalization.

Light Therapy for Neuro-inflammation and Redox Modulation

Preclinical models demonstrate that PBM attenuates microglial activation, reduces pro-inflammatory cytokine expression, and restores redox balance in models of ischemia and neurodegeneration. Such findings reinforce the view that PBM preferentially affects tissue exhibiting oxidative and inflammatory dysregulation.

Light Therapy for Autism Spectrum Disorders

Emerging evidence suggests that autism spectrum disorders (ASD) may also represent a metabolically vulnerable neurological state responsive to photobiomodulation. ASD has been associated with mitochondrial dysfunction, altered cerebral perfusion, neuroinflammation, and redox imbalance in multiple biochemical and neuroimaging studies. Preliminary clinical investigations and case series using transcranial photobiomodulation report improvements in behavioural regulation, communication, sleep quality, and executive functioning in subsets of individuals with ASD.

Proposed mechanisms include enhancement of mitochondrial ATP production, modulation of microglial activation, improved cerebral blood flow, and normalization of oxidative stress markers. Importantly, these findings are consistent with the broader literature demonstrating preferential PBM effects in metabolically compromised neural tissue. While randomised controlled trials remain limited and larger studies are required to establish standardised protocols, current data align with a homeostatic model of PBM action rather than indiscriminate cortical stimulation.

PBM prioritises metabolic dysfunctional cells

Clinical PBM literature predominantly focuses on wound healing, neuropathy, arthritis, radiation injury, and traumatic brain injury, conditions of metabolic dysfunction. Consistent outcomes include increased ATP production, reduced oxidative stress, and improved functional recovery. Healthy tissue exhibits efficient mitochondrial respiration and stable redox balance. Therefore, PBM has limited scope for further enhancement. In contrast, compromised tissue demonstrates impaired oxidative phosphorylation, making it more responsive to photobiomodulation. PBM acts preferentially in metabolically compromised tissue. Light therapy for brain health aligns with hormetic and homeostatic principles rather than simple metabolic amplification.

Please refer to our Laser Therapy for Brain and Nerve Health Services.

If you would like to discuss our service please Contact us to discuss how we may help.

Clinical Studies in Light Therapy for Brain Health